Given that RB-related proteins, RBL1 and RBL2, can functionally compensate for loss of RB in some settings (43), we investigated whether a similar RBL1/RBL2/E2F/ACSL4 axis exists in human prostate cancer. Here, ACSL4 is linked to prostate carcinoma.